Neutrophils from severe asthmatic patients induce epithelial to mesenchymal transition in healthy bronchial epithelial cells
Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated with a more severe form of asthma. There is increasing interest in the epithelial to mesenchymal transition process and mechanisms involved in...
Saved in:
Published in | Respiratory research Vol. 20; no. 1; pp. 234 - 14 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
29.10.2019
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated with a more severe form of asthma. There is increasing interest in the epithelial to mesenchymal transition process and mechanisms involved in the differentiation and repair of the airway epithelium, especially as they apply to severe asthma. Growing evidence suggests that Epithelial-Mesenchymal transition (EMT) could contribute to airway remodeling and fibrosis in asthma. Severe asthmatic patients with remodeled airways have a neutrophil driven inflammation. Neutrophils are an important source of TGF-β1, which plays a role in recruitment and activation of inflammatory cells, extracellular matrix (ECM) production and fibrosis development, and is a potent inducer of EMT.
As there is little data examining the contribution of neutrophils and/or their mediators to the induction of EMT in airway epithelial cells, the objective of this study was to better understand the potential role of neutrophils in severe asthma in regards to EMT.
We used an in vitro system to investigate the neutrophil-epithelial cell interaction. We obtained peripheral blood neutrophils from severe asthmatic patients and control subjects and examined for their ability to induce EMT in primary airway epithelial cells.
Our data indicate that neutrophils from severe asthmatic patients induce changes in morphology and EMT marker expression in bronchial epithelial cells consistent with the EMT process when co-cultured. TGF-β1 levels in the culture medium of severe asthmatic patients were increased compared to that from co-cultures of non-asthmatic neutrophils and epithelial cells.
As an inducer of EMT and an important source of TGF-β1, neutrophils may play a significant role in the development of airway remodeling and fibrosis in severe asthmatic airways. |
---|---|
AbstractList | Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated with a more severe form of asthma. There is increasing interest in the epithelial to mesenchymal transition process and mechanisms involved in the differentiation and repair of the airway epithelium, especially as they apply to severe asthma. Growing evidence suggests that Epithelial-Mesenchymal transition (EMT) could contribute to airway remodeling and fibrosis in asthma. Severe asthmatic patients with remodeled airways have a neutrophil driven inflammation. Neutrophils are an important source of TGF-β1, which plays a role in recruitment and activation of inflammatory cells, extracellular matrix (ECM) production and fibrosis development, and is a potent inducer of EMT.
As there is little data examining the contribution of neutrophils and/or their mediators to the induction of EMT in airway epithelial cells, the objective of this study was to better understand the potential role of neutrophils in severe asthma in regards to EMT.
We used an in vitro system to investigate the neutrophil-epithelial cell interaction. We obtained peripheral blood neutrophils from severe asthmatic patients and control subjects and examined for their ability to induce EMT in primary airway epithelial cells.
Our data indicate that neutrophils from severe asthmatic patients induce changes in morphology and EMT marker expression in bronchial epithelial cells consistent with the EMT process when co-cultured. TGF-β1 levels in the culture medium of severe asthmatic patients were increased compared to that from co-cultures of non-asthmatic neutrophils and epithelial cells.
As an inducer of EMT and an important source of TGF-β1, neutrophils may play a significant role in the development of airway remodeling and fibrosis in severe asthmatic airways. Background Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated with a more severe form of asthma. There is increasing interest in the epithelial to mesenchymal transition process and mechanisms involved in the differentiation and repair of the airway epithelium, especially as they apply to severe asthma. Growing evidence suggests that Epithelial-Mesenchymal transition (EMT) could contribute to airway remodeling and fibrosis in asthma. Severe asthmatic patients with remodeled airways have a neutrophil driven inflammation. Neutrophils are an important source of TGF-[beta]1, which plays a role in recruitment and activation of inflammatory cells, extracellular matrix (ECM) production and fibrosis development, and is a potent inducer of EMT. Objective As there is little data examining the contribution of neutrophils and/or their mediators to the induction of EMT in airway epithelial cells, the objective of this study was to better understand the potential role of neutrophils in severe asthma in regards to EMT. Methods We used an in vitro system to investigate the neutrophil-epithelial cell interaction. We obtained peripheral blood neutrophils from severe asthmatic patients and control subjects and examined for their ability to induce EMT in primary airway epithelial cells. Results Our data indicate that neutrophils from severe asthmatic patients induce changes in morphology and EMT marker expression in bronchial epithelial cells consistent with the EMT process when co-cultured. TGF-[beta]1 levels in the culture medium of severe asthmatic patients were increased compared to that from co-cultures of non-asthmatic neutrophils and epithelial cells. Conclusions and clinical relevance As an inducer of EMT and an important source of TGF-[beta]1, neutrophils may play a significant role in the development of airway remodeling and fibrosis in severe asthmatic airways. Keywords: Epithelial-mesenchymal transition, Airway remodeling, Severe asthma, Neutrophils, TGF-[beta]1 Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated with a more severe form of asthma. There is increasing interest in the epithelial to mesenchymal transition process and mechanisms involved in the differentiation and repair of the airway epithelium, especially as they apply to severe asthma. Growing evidence suggests that Epithelial-Mesenchymal transition (EMT) could contribute to airway remodeling and fibrosis in asthma. Severe asthmatic patients with remodeled airways have a neutrophil driven inflammation. Neutrophils are an important source of TGF-β1, which plays a role in recruitment and activation of inflammatory cells, extracellular matrix (ECM) production and fibrosis development, and is a potent inducer of EMT.BACKGROUNDAsthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated with a more severe form of asthma. There is increasing interest in the epithelial to mesenchymal transition process and mechanisms involved in the differentiation and repair of the airway epithelium, especially as they apply to severe asthma. Growing evidence suggests that Epithelial-Mesenchymal transition (EMT) could contribute to airway remodeling and fibrosis in asthma. Severe asthmatic patients with remodeled airways have a neutrophil driven inflammation. Neutrophils are an important source of TGF-β1, which plays a role in recruitment and activation of inflammatory cells, extracellular matrix (ECM) production and fibrosis development, and is a potent inducer of EMT.As there is little data examining the contribution of neutrophils and/or their mediators to the induction of EMT in airway epithelial cells, the objective of this study was to better understand the potential role of neutrophils in severe asthma in regards to EMT.OBJECTIVEAs there is little data examining the contribution of neutrophils and/or their mediators to the induction of EMT in airway epithelial cells, the objective of this study was to better understand the potential role of neutrophils in severe asthma in regards to EMT.We used an in vitro system to investigate the neutrophil-epithelial cell interaction. We obtained peripheral blood neutrophils from severe asthmatic patients and control subjects and examined for their ability to induce EMT in primary airway epithelial cells.METHODSWe used an in vitro system to investigate the neutrophil-epithelial cell interaction. We obtained peripheral blood neutrophils from severe asthmatic patients and control subjects and examined for their ability to induce EMT in primary airway epithelial cells.Our data indicate that neutrophils from severe asthmatic patients induce changes in morphology and EMT marker expression in bronchial epithelial cells consistent with the EMT process when co-cultured. TGF-β1 levels in the culture medium of severe asthmatic patients were increased compared to that from co-cultures of non-asthmatic neutrophils and epithelial cells.RESULTSOur data indicate that neutrophils from severe asthmatic patients induce changes in morphology and EMT marker expression in bronchial epithelial cells consistent with the EMT process when co-cultured. TGF-β1 levels in the culture medium of severe asthmatic patients were increased compared to that from co-cultures of non-asthmatic neutrophils and epithelial cells.As an inducer of EMT and an important source of TGF-β1, neutrophils may play a significant role in the development of airway remodeling and fibrosis in severe asthmatic airways.CONCLUSIONS AND CLINICAL RELEVANCEAs an inducer of EMT and an important source of TGF-β1, neutrophils may play a significant role in the development of airway remodeling and fibrosis in severe asthmatic airways. Abstract Background Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated with a more severe form of asthma. There is increasing interest in the epithelial to mesenchymal transition process and mechanisms involved in the differentiation and repair of the airway epithelium, especially as they apply to severe asthma. Growing evidence suggests that Epithelial-Mesenchymal transition (EMT) could contribute to airway remodeling and fibrosis in asthma. Severe asthmatic patients with remodeled airways have a neutrophil driven inflammation. Neutrophils are an important source of TGF-β1, which plays a role in recruitment and activation of inflammatory cells, extracellular matrix (ECM) production and fibrosis development, and is a potent inducer of EMT. Objective As there is little data examining the contribution of neutrophils and/or their mediators to the induction of EMT in airway epithelial cells, the objective of this study was to better understand the potential role of neutrophils in severe asthma in regards to EMT. Methods We used an in vitro system to investigate the neutrophil-epithelial cell interaction. We obtained peripheral blood neutrophils from severe asthmatic patients and control subjects and examined for their ability to induce EMT in primary airway epithelial cells. Results Our data indicate that neutrophils from severe asthmatic patients induce changes in morphology and EMT marker expression in bronchial epithelial cells consistent with the EMT process when co-cultured. TGF-β1 levels in the culture medium of severe asthmatic patients were increased compared to that from co-cultures of non-asthmatic neutrophils and epithelial cells. Conclusions and clinical relevance As an inducer of EMT and an important source of TGF-β1, neutrophils may play a significant role in the development of airway remodeling and fibrosis in severe asthmatic airways. Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated with a more severe form of asthma. There is increasing interest in the epithelial to mesenchymal transition process and mechanisms involved in the differentiation and repair of the airway epithelium, especially as they apply to severe asthma. Growing evidence suggests that Epithelial-Mesenchymal transition (EMT) could contribute to airway remodeling and fibrosis in asthma. Severe asthmatic patients with remodeled airways have a neutrophil driven inflammation. Neutrophils are an important source of TGF-[beta]1, which plays a role in recruitment and activation of inflammatory cells, extracellular matrix (ECM) production and fibrosis development, and is a potent inducer of EMT. As there is little data examining the contribution of neutrophils and/or their mediators to the induction of EMT in airway epithelial cells, the objective of this study was to better understand the potential role of neutrophils in severe asthma in regards to EMT. We used an in vitro system to investigate the neutrophil-epithelial cell interaction. We obtained peripheral blood neutrophils from severe asthmatic patients and control subjects and examined for their ability to induce EMT in primary airway epithelial cells. Our data indicate that neutrophils from severe asthmatic patients induce changes in morphology and EMT marker expression in bronchial epithelial cells consistent with the EMT process when co-cultured. TGF-[beta]1 levels in the culture medium of severe asthmatic patients were increased compared to that from co-cultures of non-asthmatic neutrophils and epithelial cells. As an inducer of EMT and an important source of TGF-[beta]1, neutrophils may play a significant role in the development of airway remodeling and fibrosis in severe asthmatic airways. |
ArticleNumber | 234 |
Audience | Academic |
Author | Mogas, Andrea K. Haddad, Alexandre Allakhverdi, Zoulfia Ludwig, Mara S. Hamid, Qutayba Audusseau, Severine Baglole, Carolyn J. Olivenstein, Ronald Gaudet, Mellissa Plesa, Maria Eidelman, David H. |
Author_xml | – sequence: 1 givenname: Alexandre surname: Haddad fullname: Haddad, Alexandre – sequence: 2 givenname: Mellissa surname: Gaudet fullname: Gaudet, Mellissa – sequence: 3 givenname: Maria surname: Plesa fullname: Plesa, Maria – sequence: 4 givenname: Zoulfia surname: Allakhverdi fullname: Allakhverdi, Zoulfia – sequence: 5 givenname: Andrea K. surname: Mogas fullname: Mogas, Andrea K. – sequence: 6 givenname: Severine surname: Audusseau fullname: Audusseau, Severine – sequence: 7 givenname: Carolyn J. surname: Baglole fullname: Baglole, Carolyn J. – sequence: 8 givenname: David H. surname: Eidelman fullname: Eidelman, David H. – sequence: 9 givenname: Ronald surname: Olivenstein fullname: Olivenstein, Ronald – sequence: 10 givenname: Mara S. surname: Ludwig fullname: Ludwig, Mara S. – sequence: 11 givenname: Qutayba surname: Hamid fullname: Hamid, Qutayba |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31665016$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktr3TAQhU1JaR7tD-imGLrpxqnGsiR7Uwihj0BoN1l0J2R5dK1gW64kBy70x1eu03BvKcVga-TvHGaGc56dTG7CLHsN5BKg5u8DlA2FgkBTrHVRP8vOoOKsaBr6_eTgfJqdh3BPCIhasBfZKQXOGQF-lv38ikv0bu7tEHLj3ZgHfECPuQqxH1W0Op_TG6cYcjt1i8YcZxt7HKwa8ujyEQNOut-Pa-nVFGy0bkps3qMaYr_PW-8SsOIHSo3DEF5mz40aAr56_F5kd58-3l1_KW6_fb65vrotNKNlLERTgaG0KTUtWctLglWHaZSSryXpBHLWVLRpO2OYFqZOoECBihHTVB29yG42286pezl7Oyq_l05Z-fvC-Z1UPk06oDQ1AJi2pYzTinVlzQSkrWmGomoZtMnrw-Y1L-2InU6L8Wo4Mj3-M9le7tyD5DU0vGLJ4N2jgXc_FgxRjjas21ATuiXIkgIRwGtGE_p2Q3cqtWYn45KjXnF5xUnFGBBWJeryH1R6OhytToExNt0fCd4cjvDU-59QJAA2QHsXgkfzhACRa9DkFjyZgrfVddKIvzTaRrVGIXVjh_8ofwE_qd4e |
CitedBy_id | crossref_primary_10_3390_ijms241411861 crossref_primary_10_1016_j_autrev_2021_103014 crossref_primary_10_1159_000512873 crossref_primary_10_3389_fimmu_2020_01134 crossref_primary_10_3389_fmed_2021_628519 crossref_primary_10_1038_s41598_024_63976_y crossref_primary_10_3390_ijms22094492 crossref_primary_10_1007_s00011_024_01859_8 crossref_primary_10_1002_cti2_1301 crossref_primary_10_3390_ijms23084086 crossref_primary_10_3390_ijms23063003 crossref_primary_10_3389_falgy_2024_1427762 crossref_primary_10_4196_kjpp_2022_26_4_239 crossref_primary_10_3892_mmr_2022_12660 crossref_primary_10_1146_annurev_pathol_042220_015902 crossref_primary_10_1183_23120541_00816_2024 crossref_primary_10_2147_JAA_S335590 crossref_primary_10_1159_000516847 crossref_primary_10_3389_falgy_2022_806391 crossref_primary_10_1016_j_lfs_2024_123326 crossref_primary_10_36691_RJA6395 crossref_primary_10_1152_ajplung_00121_2021 crossref_primary_10_20514_2226_6704_2021_12_2_113_122 crossref_primary_10_3389_falgy_2020_628381 crossref_primary_10_26442_00403660_2021_03_200661 crossref_primary_10_3390_biomedicines11082104 crossref_primary_10_3389_falgy_2022_993937 crossref_primary_10_4168_aair_2022_14_4_361 crossref_primary_10_1016_j_cbi_2022_110332 crossref_primary_10_3389_fphys_2020_559470 crossref_primary_10_1016_j_pharmthera_2025_108820 crossref_primary_10_1038_s41598_021_91087_5 crossref_primary_10_3390_ijms241512412 |
Cites_doi | 10.1067/mai.2001.119411 10.1084/jem.173.5.1121 10.1093/nar/gki965 10.1038/cr.2009.5 10.1158/1535-7163.MCT-12-1007 10.1164/ajrccm.158.6.9712073 10.1161/CIRCULATIONAHA.111.040352 10.1164/ajrccm.156.2.9609066 10.1093/molehr/gal091 10.1164/rccm.200811-1730OC 10.1164/ajrccm.156.3.9610046 10.1378/chest.07-1047 10.1111/j.1365-2222.2011.03929.x 10.1164/rccm.2108069 10.1152/ajprenal.00406.2005 10.1242/jcs.00389 10.1083/jcb.200601018 10.1681/ASN.2004050425 10.1164/ajrccm.156.2.9605065 10.1073/pnas.88.15.6805 10.1002/jcp.1041400226 10.1165/ajrcmb.17.3.2733 10.1378/chest.09-0174 10.1164/ajrccm/147.2.405 10.3892/ol.2013.1108 10.1038/nri3786 10.1136/thx.17.1.69 10.1164/ajrccm.160.3.9812110 10.1164/rccm.200306-727OC 10.1146/annurev-pathol-012414-040343 10.1067/mai.2000.110556 10.1378/chest.101.4.916 10.1165/rcmb.2006-0012OC 10.2353/ajpath.2007.061043 10.1074/jbc.M413102200 10.1016/S0140-6736(06)69288-X 10.1378/chest.07-2779 10.1016/0167-5699(95)80066-2 10.1136/thorax.57.10.875 10.1183/09059180.00004413 10.1371/journal.pone.0064281 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 BioMed Central Ltd. The Author(s). 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: The Author(s). 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1186/s12931-019-1186-8 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1465-993X |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_f8111fbb356345d28571017c5e74b51b PMC6819645 A604551054 31665016 10_1186_s12931_019_1186_8 |
Genre | Journal Article |
GeographicLocations | Canada |
GeographicLocations_xml | – name: Canada |
GrantInformation_xml | – fundername: Richard and Edith Strauss Foundation grantid: - – fundername: ; grantid: - |
GroupedDBID | --- 0R~ 29P 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PMFND 7X8 PJZUB PPXIY 5PM PUEGO |
ID | FETCH-LOGICAL-c532t-7941f3392c325b620e4de1782625b60d7e659439bdff5c7f82c37e7ea50f94d3 |
IEDL.DBID | M48 |
ISSN | 1465-993X 1465-9921 |
IngestDate | Wed Aug 27 01:15:36 EDT 2025 Thu Aug 21 17:40:38 EDT 2025 Mon Jul 21 11:07:17 EDT 2025 Tue Jun 17 21:23:38 EDT 2025 Tue Jun 10 20:44:31 EDT 2025 Thu Apr 03 06:59:10 EDT 2025 Thu Apr 24 22:53:41 EDT 2025 Tue Jul 01 02:43:16 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Epithelial-mesenchymal transition TGF-β1 Airway remodeling Severe asthma Neutrophils |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c532t-7941f3392c325b620e4de1782625b60d7e659439bdff5c7f82c37e7ea50f94d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12931-019-1186-8 |
PMID | 31665016 |
PQID | 2310716853 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f8111fbb356345d28571017c5e74b51b pubmedcentral_primary_oai_pubmedcentral_nih_gov_6819645 proquest_miscellaneous_2310716853 gale_infotracmisc_A604551054 gale_infotracacademiconefile_A604551054 pubmed_primary_31665016 crossref_primary_10_1186_s12931_019_1186_8 crossref_citationtrail_10_1186_s12931_019_1186_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-10-29 |
PublicationDateYYYYMMDD | 2019-10-29 |
PublicationDate_xml | – month: 10 year: 2019 text: 2019-10-29 day: 29 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Respiratory research |
PublicationTitleAlternate | Respir Res |
PublicationYear | 2019 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | AE Redington (1186_CR30) 1997; 156 T-L Hackett (1186_CR31) 2009; 180 GR Grotendorst (1186_CR35) 1989; 140 HE Trejo Bittar (1186_CR1) 2015; 10 G Zhou (1186_CR44) 2009; 297 BC Willis (1186_CR42) 2007; 293 M Lagraoui (1186_CR37) 1997; 43 J Ikenouchi (1186_CR18) 2003; 116 ST Holgate (1186_CR4) 2006; 368 PG Woodruff (1186_CR7) 2001; 108 JM Lee (1186_CR16) 2006; 172 B Naylor (1186_CR10) 1962; 17 R Green (1186_CR6) 2002; 57 NG Docherty (1186_CR43) 2006; 290 P Chunhacha (1186_CR19) 2013; 5 EM Minshall (1186_CR27) 1997; 17 S Gupta (1186_CR8) 2009; 136 J Xu (1186_CR15) 2009; 19 DY Rhyu (1186_CR26) 2005; 16 J Reibman (1186_CR36) 1991; 88 DE Shaw (1186_CR33) 2007; 132 RA Fava (1186_CR38) 1991; 173 T Aikawa (1186_CR12) 1992; 101 AL James (1186_CR9) 2002; 166 K-Y Lee (1186_CR24) 2006; 35 HW Chu (1186_CR39) 2000; 106 M Zeisberg (1186_CR22) 2005; 280 U Ullmann (1186_CR20) 2007; 13 N Carroll (1186_CR11) 1993; 147 SE Wenzel (1186_CR5) 1999; 160 MA Cassatella (1186_CR34) 1995; 16 C Vandewalle (1186_CR17) 2005; 33 AM Vignola (1186_CR29) 1997; 156 S Wenzel (1186_CR3) 2012; 42 PC Maffia (1186_CR25) 2007; 171 A Yasukawa (1186_CR40) 2013; 8 JC Kovacic (1186_CR21) 2012; 125 M Pain (1186_CR23) 2014; 23 C Larocca (1186_CR41) 2013; 12 RS Aysola (1186_CR14) 2008; 134 SE Wenzel (1186_CR32) 1997; 156 JV Fahy (1186_CR2) 2015; 15 H Tanaka (1186_CR13) 2003; 168 HW Chu (1186_CR28) 1998; 158 |
References_xml | – volume: 108 start-page: 753 issue: 5 year: 2001 ident: 1186_CR7 publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2001.119411 – volume: 173 start-page: 1121 year: 1991 ident: 1186_CR38 publication-title: J Exp Med doi: 10.1084/jem.173.5.1121 – volume: 33 start-page: 6566 issue: 20 year: 2005 ident: 1186_CR17 publication-title: Nucleic Acids Res doi: 10.1093/nar/gki965 – volume: 19 start-page: 156 issue: 2 year: 2009 ident: 1186_CR15 publication-title: Cell Res doi: 10.1038/cr.2009.5 – volume: 12 start-page: 1805 issue: 9 year: 2013 ident: 1186_CR41 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-12-1007 – volume: 158 start-page: 1936 issue: 6 year: 1998 ident: 1186_CR28 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.158.6.9712073 – volume: 297 start-page: L1120 issue: 6 year: 2009 ident: 1186_CR44 publication-title: Am J Phys Lung Cell Mol Phys – volume: 125 start-page: 1795 issue: 14 year: 2012 ident: 1186_CR21 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.040352 – volume: 156 start-page: 591 issue: 2 year: 1997 ident: 1186_CR29 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.156.2.9609066 – volume: 13 start-page: 21 issue: 1 year: 2007 ident: 1186_CR20 publication-title: Mol Hum Reprod doi: 10.1093/molehr/gal091 – volume: 180 start-page: 122 issue: 2 year: 2009 ident: 1186_CR31 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200811-1730OC – volume: 156 start-page: 737 issue: 3 year: 1997 ident: 1186_CR32 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.156.3.9610046 – volume: 132 start-page: 1871 issue: 6 year: 2007 ident: 1186_CR33 publication-title: CHEST doi: 10.1378/chest.07-1047 – volume: 42 start-page: 650 issue: 5 year: 2012 ident: 1186_CR3 publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2011.03929.x – volume: 166 start-page: 1590 issue: 12 year: 2002 ident: 1186_CR9 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.2108069 – volume: 290 start-page: F1202 issue: 5 year: 2006 ident: 1186_CR43 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00406.2005 – volume: 116 start-page: 1959 issue: 10 year: 2003 ident: 1186_CR18 publication-title: J Cell Sci doi: 10.1242/jcs.00389 – volume: 172 start-page: 973 issue: 7 year: 2006 ident: 1186_CR16 publication-title: J Cell Biol doi: 10.1083/jcb.200601018 – volume: 16 start-page: 667 issue: 3 year: 2005 ident: 1186_CR26 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2004050425 – volume: 156 start-page: 642 issue: 2 year: 1997 ident: 1186_CR30 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.156.2.9605065 – volume: 88 start-page: 6805 issue: 15 year: 1991 ident: 1186_CR36 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.88.15.6805 – volume: 43 start-page: 313 issue: 3 year: 1997 ident: 1186_CR37 publication-title: Cell Mol Biol (Noisy-le-Grand, France) – volume: 140 start-page: 396 issue: 2 year: 1989 ident: 1186_CR35 publication-title: J Cell Physiol doi: 10.1002/jcp.1041400226 – volume: 17 start-page: 326 issue: 3 year: 1997 ident: 1186_CR27 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/ajrcmb.17.3.2733 – volume: 293 start-page: L525 issue: 3 year: 2007 ident: 1186_CR42 publication-title: Am J Phys Lung Cell Mol Phys – volume: 136 start-page: 1521 issue: 6 year: 2009 ident: 1186_CR8 publication-title: CHEST Journal doi: 10.1378/chest.09-0174 – volume: 147 start-page: 405 year: 1993 ident: 1186_CR11 publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/147.2.405 – volume: 5 start-page: 1043 issue: 3 year: 2013 ident: 1186_CR19 publication-title: Oncol Lett doi: 10.3892/ol.2013.1108 – volume: 15 start-page: 57 issue: 1 year: 2015 ident: 1186_CR2 publication-title: Nat Rev Immunol doi: 10.1038/nri3786 – volume: 17 start-page: 69 issue: 1 year: 1962 ident: 1186_CR10 publication-title: Thorax doi: 10.1136/thx.17.1.69 – volume: 160 start-page: 1001 issue: 3 year: 1999 ident: 1186_CR5 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.160.3.9812110 – volume: 168 start-page: 1495 issue: 12 year: 2003 ident: 1186_CR13 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200306-727OC – volume: 10 start-page: 511 year: 2015 ident: 1186_CR1 publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-012414-040343 – volume: 106 start-page: 1115 issue: 6 year: 2000 ident: 1186_CR39 publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2000.110556 – volume: 101 start-page: 916 issue: 4 year: 1992 ident: 1186_CR12 publication-title: Chest doi: 10.1378/chest.101.4.916 – volume: 35 start-page: 407 issue: 4 year: 2006 ident: 1186_CR24 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2006-0012OC – volume: 171 start-page: 928 issue: 3 year: 2007 ident: 1186_CR25 publication-title: Am J Pathol doi: 10.2353/ajpath.2007.061043 – volume: 280 start-page: 8094 issue: 9 year: 2005 ident: 1186_CR22 publication-title: J Biol Chem doi: 10.1074/jbc.M413102200 – volume: 368 start-page: 780 issue: 9537 year: 2006 ident: 1186_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(06)69288-X – volume: 134 start-page: 1183 issue: 6 year: 2008 ident: 1186_CR14 publication-title: CHEST doi: 10.1378/chest.07-2779 – volume: 16 start-page: 21 issue: 1 year: 1995 ident: 1186_CR34 publication-title: Immunol Today doi: 10.1016/0167-5699(95)80066-2 – volume: 57 start-page: 875 issue: 10 year: 2002 ident: 1186_CR6 publication-title: Thorax doi: 10.1136/thorax.57.10.875 – volume: 23 start-page: 118 issue: 131 year: 2014 ident: 1186_CR23 publication-title: Eur Respir Rev doi: 10.1183/09059180.00004413 – volume: 8 start-page: e64281 issue: 5 year: 2013 ident: 1186_CR40 publication-title: PLoS One doi: 10.1371/journal.pone.0064281 |
SSID | ssj0017875 |
Score | 2.4286146 |
Snippet | Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is associated... Background Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway remodeling is... Abstract Background Asthma is a heterogenous disease characterized by chronic inflammation and airway remodeling. An increase in the severity of airway... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 234 |
SubjectTerms | Adult Airway remodeling Asthma Asthma - metabolism Asthma - pathology Bronchi - cytology Bronchi - metabolism Care and treatment Cells, Cultured Coculture Techniques - methods Culture Media, Conditioned - pharmacology Development and progression Epithelial-mesenchymal transition Epithelial-Mesenchymal Transition - drug effects Epithelial-Mesenchymal Transition - physiology Female Gene expression Genetic aspects Health aspects Humans Male Middle Aged Neutrophils Neutrophils - metabolism Respiratory Mucosa - metabolism Severe asthma Severity of Illness Index TGF-β1 Transforming growth factors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlh9JL6UfaOk2KCoFCwcS2LFk-JiEhFJJTCrkJSxqxgY29rL2HQH98Z2ztsqbQXnqUJYGsmfG8sWaeGDsNErAriLT2NQYoUNdpA0KlXtjGWwll8PQf8vZO3fwsfzzIh72rvignbKIHnjbuLGi0xmCtkEqU0hdaVqRFTkJVWplb-vqiz9sGU_H8ANVQxjPMXKuznrwahc11Su1Uz7zQSNb_5yd5zyfN8yX3HND1G_Y6Ikd-Pq34LXsB7Tv28jaejb9nv-5gM6y71eJx2XOqGuHo9GANvOmHxUjMyiOJas8xEEeRclhRRcYSVZAPHX-iQiS3eH6iJrmwMZsLx_KpWPKZ23XXUm70cn8m_frvD9n99dX95U0a71ZInRTFkKIZ5kEgOHKikFYVGZQecNsKRc3MV6BkjWDF-hCkq4LGgRVU0Mgs1KUXH9hB27XwifFGySLgTEDsWDqhrfONAOnBKuGqzCcs2261cZF3nK6_WJox_tDKTNIxKJ2prRP2fTdlNZFu_G3wBclvN5D4sscHqEUmapH5lxYl7BtJ35BV4-JcE4sT8BWJH8ucK4S-hEXLhB3PRqI1uln3163-GOqiFLYWuk1vCEhjcIrwKGEfJ33arVnkCpFyrhJWzTRt9lLznvZxMZKBK02UavLof-zCZ_aqGG0kS4v6mB0M6w2cIOYa7JfRvH4DYlcqeA priority: 102 providerName: Directory of Open Access Journals |
Title | Neutrophils from severe asthmatic patients induce epithelial to mesenchymal transition in healthy bronchial epithelial cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31665016 https://www.proquest.com/docview/2310716853 https://pubmed.ncbi.nlm.nih.gov/PMC6819645 https://doaj.org/article/f8111fbb356345d28571017c5e74b51b |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBf9gNKXse957YIGg8HAm2NZkv0wRjpaSiBhbC3kzVhfTSG1M9uBBvbH7852spiVPezJyDoZW3en-52luyPkneMWuhzzE5OAg2KTxM8sE75hKjOK28gZ_A85mYrL62g847M9silv1U1g9aBrh_WkrsvFx_uf6y-g8J8bhY_FpwptFjrFiY9tP94nh2CYJOrpJPqzqQCyydtgI-4nSTjsNjkffMQxOWJDAfAFC6HvWKwmsf_fy_eO_eqfrdwxVhePyaMOZdJRKxZPyJ7Nn5KjSbeP_oz8mtpVXRbL-e2iohhhQsFA2tLSrKrnTRJX2iVcrSg47cB-apcYvbEAcaV1Qe8waEnP13fYRHPXnPwCWtoGVq6pKoscz1EvdkfiNkH1nFxdnF99vfS7Ogy-5iysfVDZoWMApDQLuRJhYCNjYTZDgc3ASCt4AsBGGee4li4GQmmlzXjgksiwF-QgL3L7itBM8NDBSAs4M9IsVtpkzHJjlWBaBsYjwWaqU93lKMdSGYu08VVikbaMSoFRbTv2yIftkGWboONfxGfIvy0h5tZubhTlTdqpaupiWP-dUowLFnETxlziuqW5lZHiQ-WR98j9FGUSXk5nXSADfCLm0kpHAmAy4tbII6c9StBc3et-u5GfFLvwuFtui1WVIugGRxaglEdetvK0feeNWHpE9iSt91H9nvx23iQOFzGmX-Ov_3vkCTkOGx0J_DA5JQd1ubJvAJTVakD25UwOyOFoNP4xhuvZ-fTb90Hzi2PQqOFv0u06Rg |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutrophils+from+severe+asthmatic+patients+induce+epithelial+to+mesenchymal+transition+in+healthy+bronchial+epithelial+cells&rft.jtitle=Respiratory+research&rft.au=Haddad%2C+Alexandre&rft.au=Gaudet%2C+Mellissa&rft.au=Plesa%2C+Maria&rft.au=Allakhverdi%2C+Zoulfia&rft.date=2019-10-29&rft.pub=BioMed+Central&rft.issn=1465-9921&rft.eissn=1465-993X&rft.volume=20&rft_id=info:doi/10.1186%2Fs12931-019-1186-8&rft_id=info%3Apmid%2F31665016&rft.externalDocID=PMC6819645 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon |